{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78106",
      "recalling_firm": "Aidarex Pharmaceuticals LLC",
      "address_1": "595 N Smith Ave Ste B",
      "address_2": "N/A",
      "postal_code": "92880-6920",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Product was distributed in Florida",
      "recall_number": "D-0053-2018",
      "product_description": "ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90.",
      "product_quantity": "12 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.",
      "recall_initiation_date": "20170905",
      "center_classification_date": "20171026",
      "termination_date": "20171201",
      "report_date": "20171101",
      "code_info": "Lot #: 55097-2, 56085-1, Exp 11/30/2018"
    }
  ]
}